121 related articles for article (PubMed ID: 17259654)
1. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.
Gemignani F; Landi S; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Gaborieau V; Gioia-Patricola L; Bellini I; Barale R; Canzian F; Hall J; Boffetta P; Hung RJ; Brennan P
Carcinogenesis; 2007 Jun; 28(6):1287-93. PubMed ID: 17259654
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway.
Skuladottir H; Autrup H; Autrup J; Tjoenneland A; Overvad K; Ryberg D; Haugen A; Olsen JH
Lung Cancer; 2005 May; 48(2):187-99. PubMed ID: 15829318
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Mutat Res; 2008 May; 641(1-2):12-8. PubMed ID: 18358500
[TBL] [Abstract][Full Text] [Related]
5. DNA repair and cell cycle control genes and the risk of young-onset lung cancer.
Landi S; Gemignani F; Canzian F; Gaborieau V; Barale R; Landi D; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Gioia-Patricola L; Hall J; Boffetta P; Hung RJ; Brennan P
Cancer Res; 2006 Nov; 66(22):11062-9. PubMed ID: 17108146
[TBL] [Abstract][Full Text] [Related]
6. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
[TBL] [Abstract][Full Text] [Related]
8. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
[TBL] [Abstract][Full Text] [Related]
9. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
10. Phenotype prediction of nonsynonymous single nucleotide polymorphisms in human phase II drug/xenobiotic metabolizing enzymes: perspectives on molecular evolution.
Hao D; Xiao P; Chen S
Sci China Life Sci; 2010 Oct; 53(10):1252-62. PubMed ID: 20953949
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the Caspase7 gene and the risk of lung cancer.
Lee WK; Kim JS; Kang HG; Cha SI; Kim DS; Hyun DS; Kam S; Kim CH; Jung TH; Park JY
Lung Cancer; 2009 Jul; 65(1):19-24. PubMed ID: 19058873
[TBL] [Abstract][Full Text] [Related]
12. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.
Timofeeva MN; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude JC; Risch A; Wichmann HE
Carcinogenesis; 2009 Jul; 30(7):1161-9. PubMed ID: 19414505
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
14. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
Sauter W; Rosenberger A; Beckmann L; Kropp S; Mittelstrass K; Timofeeva M; Wölke G; Steinwachs A; Scheiner D; Meese E; Sybrecht G; Kronenberg F; Dienemann H; ; Chang-Claude J; Illig T; Wichmann HE; Bickeböller H; Risch A
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1127-35. PubMed ID: 18483334
[TBL] [Abstract][Full Text] [Related]
16. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2.
Köhle C; Bock KW
Biochem Pharmacol; 2007 Jun; 73(12):1853-62. PubMed ID: 17266942
[TBL] [Abstract][Full Text] [Related]
17. Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.
Hu Z; Liu H; Wang H; Miao R; Sun W; Jin G; Wang Y; Ma H; Jin L; Wei Q; Lu D; Huang W; Shen H
Clin Cancer Res; 2008 May; 14(9):2887-91. PubMed ID: 18451257
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
19. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.
Gemignani F; Neri M; Bottari F; Barale R; Canessa PA; Canzian F; Ceppi M; Spitaleri I; Cipollini M; Ivaldi GP; Mencoboni M; Scaruffi P; Tonini GP; Ugolini D; Mutti L; Bonassi S; Landi S
Mutat Res; 2009 Dec; 671(1-2):76-83. PubMed ID: 19751749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
